In a world-first clinical trial, lab-grown red blood cells have been transfused into humans. If successful, its continuation will bolster supplies for those with rare blood types and improve treatment for people who require regular transfusions.
You’ve heard of lab-grown meat, but what about lab-grown human blood?
For the very first time, a couple of spoonfuls (5-10ml) of lab-grown blood have been injected into volunteers participating in the RESTORE randomised controlled clinical trial in the UK.
These trials, if successful, would help to meet blood supplies for people with unique blood types. Professors at the University of Bristol said certain blood groups are so rare that they can only find matches in 10 people across the UK.
Looking to the future, lab-manufactured blood cells could revolutionise treatment for patients with rare blood types and conditions such as sickle cell and thalassemia.
Those living with these diseases rely on donated blood for regular transfusions, which can become more complex to accomplish over time.
Scientists started manufacturing lab-grown red blood cells using stem cells from human blood donors.
They have anticipated that cells grown in the lab will outperform standard donated blood, as the lab-grown cells are far fresher. If correct, this would mean that patients regularly receiving blood transfusions won’t need to get them as often.
Better performing lab-grown cells would also mean fewer transfusions needed per patient. This would lower the risk of patients experiencing iron overload, a complication sometimes seen in people receiving regular blood transfusions.
Dr Farrukh Shah, Medical Director of Transfusion for NHS Blood and Transplant, said:
‘Patients who need regular or intermittent blood transfusions may develop antibodies against minor blood groups. [This] makes it harder to find donor blood which can be transfused without the risk of a potentially life-threatening reaction.’
Monitoring the results
The NIHR Cambridge Clinical Research Facility is overseeing the clinical trial, having recruited two healthy volunteers.
So far, the two volunteers are healthy and well, showing no side effects. In the coming months, a minimum of ten more volunteers are expected to receive two mini-transfusions – both lab-grown and traditional – at least four months apart.
The goal of this dual trial is to compare the lifespan of the two types of blood donations in the body, to see whether lab-grown blood is longer-lasting in its positive effects.
Hopefully, the success of the trial will advance the mission to make lab-grown red blood cells more widely available for people who need it.
Professor Lucy Chappell, Chief Executive of the NIHR said:
‘These NIHR-supported researchers have made it possible to grow blood in the lab, turning what sounds like science fiction into a ground-breaking reality… This is really exciting progress that is another example of the world-leading life sciences opportunities that the UK has to offer.’
Fingers crossed the trial goes well, as over 2.5 million units of blood are transfused into UK patients by the NHS every year!
Deputy Editor & Content Partnership ManagerLondon, UK
I’m Jessica (She/Her). I’m the Deputy Editor & Content Partnership Manager at Thred. Originally from the island of Bermuda, I specialise in writing about ocean health and marine conservation, but you can also find me delving into pop culture, health and wellness, plus sustainability in the beauty and fashion industries. Follow me on Twitter, LinkedIn and drop me some ideas/feedback via email.
A diminishing appetite for booze has ushered in a new, downsized, era for the cocktail.
It’s been reported for some time now that young people are drinking less. Our parent’s generation were privy to the 80s cocktail goldrush, whetted with Piña Coladas and Blue Lagoons. And millennials have held up national drinking standards having come of age in the alcopop era.
But for many people my age (I sit on the...
While billions have been poured into manufacturing hydrogen the dirty way, experts in Canada found what was once thought to be impossible: a steady stream of white hydrogen.
Last year, thanks to a surge in solar panel installations, the world raved about how renewables overtook coal to become one of the largest suppliers of energy. Not to burst that bubble, but as great as that achievement is, it only...
A month ago, local election results dominated UK political headlines. Reform UK celebrated historic gains, Liberal Democrats became a fan favourite, and Greens climbed up the ladder.
Now that maps have stopped changing colour and victory speeches are over, the dust has finally settled and perhaps the most interesting question isn’t who won the local elections, but what they actually tell us about the state of British politics.
For many young...
French authorities arrested over 400 people due to clashes between football fans following the Champions League final.
More than 400 arrests were made across France following Paris Saint-Germain (PSG)'s victory over Arsenal on Saturday evening, with clashes erupting between fans and police in Paris and other cities. Vehicles were damaged and businesses vandalised, officers injured and tear gas deployed. As is often the case after major league games, by...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
0 comments
